At a glance
The April 13, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on serology testing and biosafety, as well as presentations from various laboratories, the U.S Department of Transportation (DOT), FDA, and healthcare councils.
Agenda
Welcome and Introductions: Jasmine Chaitram, CDC Division of Laboratory Systems
The Reference Lab Experience: Lessons Learned and Ongoing Lessons: Marc Couturier, ARUP Laboratories
New York State Public Health Laboratory Experience: Kirsten St. George, New York State Public Health Laboratory at Wadsworth
Serology Testing Update: Michele Owen, CDC Laboratory Task Force
Category B vs. Materials of Trade (MOT) Specimen Packaging and Shipping: Stuart Streck, U.S. Department of Transportation (DOT)
Home Specimen Collection Kits, Home Testing, Serology, Point-of-Care Testing, and Other Topics: Tim Stenzel and Sara Brenner, U.S. Food and Drug Administration (FDA)
Working with Healthcare Providers to Obtain Demographic Data: Janet Hamilton, Council for State and Territorial Epidemiologists (CSTE)
Laboratory Biosafety Update for COVID-19: Bill Arndt, CDC Division of Laboratory Systems